<?xml version="1.0" encoding="UTF-8"?>
<title-group>
 <article-title>Reprofiling of pyrimidine-based DAPK1/CSF1R dual inhibitors: identification of 2,5-diamino-4-pyrimidinol derivatives as novel potential anticancer lead compounds</article-title>
 <alt-title alt-title-type="left-running-head">A. K. Farag et al.</alt-title>
</title-group>
